Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis

Critical Care Medicine

Volumn 34, Issue 5, 2006, Pages 1456-1463

  Krejci, Vladimir ^a   Hiltebrand, Luzius B ^a   Sigurdsson, Gisli H ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Intestine; Liver; Microcirculation; Pancreas; Vasoconstrictors

Indexed keywords

ADRENALIN; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD FLOW; COLON MUCOSA; CONTINUOUS INFUSION; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HEART INDEX; HYPOTENSION; INTESTINE BLOOD FLOW; JEJUNUM; KIDNEY BLOOD FLOW; LASER DOPPLER FLOWMETRY; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; PANCREAS BLOOD FLOW; PERFUSION PRESSURE; PERITONITIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STOMACH BLOOD FLOW; SWINE; SYSTEMIC CIRCULATION; TONOMETRY; VASOCONSTRICTION; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EVALUATION; HEMODYNAMICS; INTESTINE; LIVER; PANCREAS; RANDOMIZATION; SPLANCHNIC BLOOD FLOW; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CROSS-OVER STUDIES; EPINEPHRINE; HEMODYNAMIC PROCESSES; INTESTINES; LIVER; MICROCIRCULATION; NOREPINEPHRINE; PANCREAS; PHENYLEPHRINE; RANDOM ALLOCATION; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; SWINE; VASOCONSTRICTOR AGENTS;

EID: 33646547249     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000215834.48023.57     Document Type: Article

References (46)

1. Shoemaker W, Appel P, Kram H: Hemodynamic and oxygen transport responses in survivors and nonsurvivors of high risk surgery. Crit Care Med 1993; 21:977-990
2. Boyd O, Grounds M, Bennett E: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993; 270:2699-2707
3. Ruokonen E, Takala J, Kari A, et al: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296-1303
4. Fink MP: Adequacy of gut oxygenation in endotoxemia and sepsis. Crit Care Med 1993; 21:S4-S8
5. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 1999; 27:639-660
6. Sigurdsson GH: Is translocation of bacteria and endotoxin from the gastrointestinal tract a source of sepsis in the critically ill? Acta Anaesthesiol Scand 1995; 39:11-19
7. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-2086
8. Spain DA, Wilson MA, Krysztopik RJ, et al: Differential intestinal microvascular dysfunction occurs during bacteremia. J Surg Res 1997; 67:67-71
9. Takakura K, Taniguchi T, Muramatsu I, et al: Modification of alpha1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med 2002; 30:894-899
10. Sautner T, Wessely C, Riegler M, et al: Early effects of catecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxin shock. Ann Surg 1998; 228:239-248
11. Sigurdsson GH, Christenson JT, El-Rakshy MB, et al: Intestinal platelet sequestration after traumatic and septic shock. An early sign of sepsis and multiple organ failure in critically ill patients? Crit Care Med 1992; 20:458-467
12. Uusaro A, Ruokonen E, Takala J: Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 1995; 30:106-112
13. Reinelt H, Radermacher P, Kiefer P, et al: Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999; 27:325-331
14. Jakob SM, Takala J: Variability of splanchnic blood flow measurements in patients with sepsis - Physiology, pathophysiology or measurement errors? Intensive Care Med 2001; 27:1692-1695
15. Sakka SG, Reinhart K, Wegscheider K, et al: Variability of splanchnic blood flow in patients with sepsis. Intensive Care Med 2001; 27:1281-1287
16. Seguin P, Bellissant E, Le Tulzo Y, et al: Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002; 71:381-388
17. Duranteau J, Sitbon P, Teboul J, et al: Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999; 27:893-900
18. Hiltebrand LB, Krejci V, Banic A, et al: Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med 2000; 28:3233-3241
19. Hannon JP, Bossone CA, Rodkey WG: Splenic red cell sequestration and blood volume measurements in conscious pigs. Am J Physiol 1985; 248:R293-R301
20. Groeneveld AB, Kolkman JJ: Splanchnic tonometry: A review of physiology, methodology, and clinical applications. J Crit Care 1994; 9:198-210
21. Almond NE, Wheatley AM: Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 1992; 262:G203-G209
22. Kuznetsova LV, Tomasek N, Sigurdsson GH, et al: Dissociation between volume blood flow and laser-Doppler signal from rat muscle during changes in vascular tone. Am J Physiol 1998; 274:H1248-H1254
23. Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831
24. Hiltebrand L, Krejci V, Ten Hoevel M, et al: Redistribution of microcirculatory blood flow within the intestinal wall during sepsis and general anesthesia. Anesthesiology 2003; 98:658-669
25. Dodds W: The pig model for biomedical research. Fed Proc 1982; 41:247-256
26. Johnson P: Autoregulation of blood flow. Circ Res 1986; 59:483-495
27. Reisbeck M, Astiz ME: Arterial pressure, vasopressors and septic shock: Higher is not necessarily better. Crit Care Med 2005; 33:906-907
28. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
29. Marin C, Eon B, Akin P, et al: Renal effects of norepinephrine used to treat septic shock. Crit Care Med 1990; 18:282-285
30. Ledoux D, Astiz M, Carpati C, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732
31. Bourgoin A, Leone M, Delmas A, et al: Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function. Crit Care Med 2005; 33:780-786
32. Hollenberg SM, Ahrens TS, Annane D, et al: Task Force of the American College of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 2004; 32:1928-1948
33. Krejci V, Hiltebrand LB, Erni D, et al: Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 2003; 31:203-210
34. Shepherd AP, Riedel GL: Intramural distribution of intestinal blood flow during sympathetic stimulation. Am J Physiol 1988; 255:H1091-H1095
35. Banic A, Krejci V, Erni D, et al: Effects of sodium nitroprusside and phenylephrine on blood flow in free musculocutaneous flaps during general anesthesia. Anesthesiology 1999; 90:147-155
36. Flancbaum L, Dick M, Dasta J, et al: A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997; 51:461-465
37. Gregory J, Bonfiglio M, Dasta J, et al: Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19:1395-1400
38. Kakizoe E, Kobayashi Y, Shimoura K, et al: Spectrophotometric study of alpha-adrenoceptors affecting microcirculation of rat skin. Clin Exp Pharmacol Physiol 1993; 20:421-427
39. Lobo SM, Salgado PF, Castillo VG, et al: Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28:3396-3404
40. Yu M, Levy MM, Smith P, et al: Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study. Crit Care Med 1993; 21:830-838
41. De Backer D, Creteur J, Noordally O, et al: Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998; 157:1219-1225
42. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025-1032
43. Alia I, Esteban A, Gordo F, et al: A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 1999; 115:453-461
44. Levy B, Bollaert P, Charpentier C, et al: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997; 23:282-287
45. Jakob SM, Merasto-Minkkinen M, Tenhunen JJ, et al: Prevention of systemic hyperlactatemia during splanchnic ischemia. Shock 2000; 14:123-127
46. Meier-Hellmann A, Reinhart K, Bredle DL, et al: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997; 25:399-404